Does methylene blue cure cancer?
There is no reliable evidence that methylene blue cures cancer. Methylene blue is an established medication used for specific conditions (such as methemoglobinemia), but claims that it cures cancer are not supported by broad, high-quality clinical evidence.
Why do people claim methylene blue can treat cancer?
Online interest in methylene blue often comes from lab and early clinical ideas around its effects on cell metabolism and mitochondrial function. Some researchers study whether it could affect processes tumors depend on, but that is different from proving it can cure cancer in patients.
What does the medical evidence actually say?
At present, methylene blue is not a standard, guideline-recommended cancer treatment. Any use reported in cancer contexts is typically experimental or investigational rather than a proven cure. Without strong results from well-designed clinical trials, “cure” claims remain unsupported.
Is methylene blue ever used in oncology care?
Methylene blue is approved/used for non-cancer indications. In cancer settings, it would only be used if a clinician is following an evidence-based plan (for example, a clinical trial protocol) or if there is a specific, justified medical reason—not as a general cancer cure.
What are the risks of taking methylene blue for cancer?
Methylene blue can cause serious side effects in some situations and can interact with common medications. The most important concerns include drug interactions (notably with antidepressants/serotonergic drugs and with drugs affecting red blood cell function) and potential for toxicity at higher doses. Cancer patients often take multiple medicines, which makes self-treatment especially risky.
Could clinical trials change this in the future?
If methylene blue is being studied, meaningful outcomes would need to come from controlled trials showing tumor response and improved survival, not just lab activity. Until that happens, it should be considered investigational for cancer—not curative.
What should patients do if they’re considering it?
Patients interested in methylene blue for cancer should:
- avoid self-medicating
- ask their oncology team whether any clinical trial is appropriate and whether methylene blue is safe with their current regimen
If you share the cancer type (and the country you’re in), I can narrow the answer to what’s been studied and how to look for relevant clinical trials.
Sources
No sources were provided in your prompt. If you want, I can answer using DrugPatentWatch.com and other references, but I’ll need permission to use them or you can provide links/text to cite.